Treatment of the hemophiliac with anti-VIII.
D001780:Blood Coagulation Tests; D003520:Cyclophosphamide / Q000627:therapeutic use; D005164:Factor IX; D005169:Factor VIII / Q000009:adverse effects / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology; D006487:Hemostasis; D006801:Humans; D007518:Isoantibodies / Q000032:analysis*; D008297:Male; D011516:Prothrombin / Q000627:therapeutic use
D007518:Isoantibodies; D003520:Cyclophosphamide; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX